Moderna receives MHRA marketing authorization for RSV vaccine
Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency in the UK has granted marketing authorization for mRESVIA, indicated for active immunization for the prevention of ...
devdiscourse1h
Global Health Updates: U.S. Agency Involvement, Vaccine Approvals, and Market Strategies
Recent health news highlights include U.S. agency participation in a WHO meeting despite a planned exit, the UK's approval of ...
devdiscourse17h
Global Health Headlines: Impacts and Innovations
Health updates cover U.S. involvement in WHO meetings, UK approval of Moderna's RSV vaccine, a Texas measles outbreak, FDA ...
Health and Me on MSN17h
UK Approves RSV Vaccination For Ages 60 And Over
The shot, also known as the mRESVIA is used for preventing the lower respiratory tract disease in older adults. As per the ...